Allergan plc Ordinary Shares (AGN): PT Lowered News

AGN – JPMorgan cuts price target to $245 from $265. This new price target represents a 41.13% upside over the stock’s previous closing price of $173.60.

Update: As of Mar. 26, 2019, this bearish analyst call has returned -14.20%.

Key Facts Surrounding This News Item

  • AGN had a POWR Rating of C (Neutral) coming into today.
  • AGN was 3.06% above its 10-Day Moving Average coming into today.
  • AGN was 2.52% above its 20-Day Moving Average coming into today.
  • AGN was 9.33% above its 50-Day Moving Average coming into today.
  • AGN was 9.57% above its 100-Day Moving Average coming into today.
  • AGN was 3.97% above its 200-Day Moving Average coming into today.
  • AGN had returned +8.53% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Allergan plc Ordinary Shares (AGN)

Allergan plc markets products that provide treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women’s health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world’s third-largest global generics business. The company was founded in 1983 and is based in Parsippany, New Jersey. View our full AGN ticker page with ratings, news, and more.

AGN at a Glance

AGN Current POWR Rating™
Overall POWR Rating™
AGN Current Price $148.94 1.78%
More AGN Ratings, Data, and News

AGN Price Reaction

The day of this event (Jul. 11, 2018)
AGN Closing Price$172.08 0.88%
AGN Volume1,393,631
54.00% from avg
Leading up to this event
AGN 1-mo return2.87%
After this event
AGN 1-day return0.32%
AGN 3-day return0.17%
AGN 5-day return0.05%

AGN Price Chart

More Allergan plc Ordinary Shares (AGN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All AGN News
Page generated in 0.8086 seconds.